Evidence map›Paper›PMID 35933666›Full record

ArticleThe Permanente journal2022

Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic.

Annie Tang, Elad Neeman, Gillian E Kuehner, Alison C Savitz, Margaret Mentakis, Brooke Vuong, Vignesh A Arasu, Raymond Liu, Liisa L Lyon, Prachi Anshu and 7 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Permanente journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Annie TangDepartment of Surgery, University of California San Francisco, Oakland, CA, USA.
Elad NeemanDepartment of Medical Oncology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
Gillian E KuehnerDepartment of Surgery, Kaiser Permanente Vallejo Medical Center, Vallejo, CA, USA.
Alison C SavitzDepartment of Surgery, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, CA, USA.
Margaret MentakisDepartment of Surgery, Kaiser Permanente South Sacramento Medical Center, Sacramento, CA, USA.
Brooke VuongDepartment of Surgery, Kaiser Permanente South Sacramento Medical Center, Sacramento, CA, USA.
Vignesh A ArasuDepartment of Radiation Oncology, Kaiser Permanente Vallejo Medical Center, Vallejo, CA, USA.
Raymond LiuDepartment of Medical Oncology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
Liisa L LyonKaiser Permanente Northern California Division of Research, Oakland, CA, USA.
Prachi AnshuDrexel University School of Medicine, Philadelphia, USA.
Samantha A SeawardDepartment of Radiation Oncology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Milan D PatelDepartment of Radiation Oncology, Kaiser Permanente South San Francisco Medical Center, South San Francisco, CA, USA.
Laurel A HabelKaiser Permanente Northern California Division of Research, Oakland, CA, USA.
Lawrence H KushiKaiser Permanente Northern California Division of Research, Oakland, CA, USA.
Eva S ThomasDepartment of Medical Oncology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Tatjana KolevskaDepartment of Medical Oncology, Kaiser Permanente Vallejo Medical Center, Vallejo, CA, USA.
Sharon B ChangDepartment of Surgery, Kaiser Permanente Fremont Medical Center, Fremont, CA, USA.
Kaiser Permanente · USKaiser Permanente Vallejo Medical Center · USKaiser Permanente Oakland Medical Center · USKaiser Permanente South Sacramento Medical Center · USDrexel University · USKaiser Permanente San Francisco Medical Center · USKaiser Permanente South San Francisco Medical Center · USKaiser Permanente Walnut Creek Medical Center · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction The COVID-19 pandemic drove rapid, widespread adoption of telehealth (TH). We evaluated surgical telehealth utilization and outcomes for newly diagnosed breast cancer patients during the initial pandemic period. Methods We identified patients with breast cancer diagnosed March 17, 2020 through May 17, 2020 who underwent surgery as the initial treatment. Clinicodemographic characteristics were collected. Initial consultation types (office, telephone, or video) were categorized. Outcomes included time to consultation, surgeon touchpoints, time to surgery, surgery types, and reexcision rates. Continuous variables were compared using Mann-Whitney tests or

Indexed as

Breast NeoplasmsCOVID-19TelemedicineFemaleHumansPandemicsSARS-CoV-2breastpreoperativesurgerytelehealthtiming

Identifiers

PMID35933666
PMCPMC9662263
OpenAlexW4283693997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.